Composition

Each single-dose vial contains: Tocilizumab 400 mg in 20 mL concentrate (20 mg/mL). Tocilizumab is a humanised IgG1 monoclonal antibody against the human interleukin-6 (IL-6) receptor produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology Excipients with known effects: Each 400 mg vial contains 0.39 mmol (8.85 mg) Sodium  

ATC Code

L04AC07  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

20 mL x 1’s; 20 mL x 4’s (in vials)  

Product Description

Concentrate for solution for IV infusion in single-dose 20-mL vial. A preservative-free, sterile clear, colourless to pale yellow solution

Manufacturer Name

Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant

Manufacturer Country

JAPAN  

Approval Date

2022-12-18  

Expiry Date

2027-12-17